secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001437749-24-006421
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics reports record 2023 revenue of $18.3M, up 42% YoY
--------------------------------------------------------------

- Full-year 2023 revenue $18.3M (FY22: $12.9M); sold 151 EksoHealth units.
- Q4 2023 revenue $4.8M (+36% YoY); gross margin 49% vs 47%.
- Net loss FY23 $15.2M ($1.10/sh) vs $15.1M ($1.16/sh) in FY22.
- Cash at Dec 31, 2023: $8.6M, down from $20.5M; raised $3.9M in Jan 2024 offering.
- CMS deferred payment determination for personal exoskeletons (Ekso Indego Personal).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924006421/0001437749-24-006421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924006421/ekso20240302_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer